Literature DB >> 22860300

[Pain treatment with low reactive level laser therapy (LLLT)].

Toyoshi Hosokawa1, Yasuyo Kawabata.   

Abstract

Noninvasive and low reactive level laser (LLLT) is used as one of the light therapies without giving pain to the patient. Therefore, it is used often clinically in pain treatment, orthopedics, plastic surgery, dermatology, and dentistry. In the pain clinic field, it is one of the procedures indispensable to treatment of various pain including postherpetic neuralgia, diabetic neuropathy or myofascial pain. In recent years the mechanism has been gradually elucidated by basic study. The action is on sensory nerve, sympathetic nerve, blood vessel, immunity, inflammation and central nervous system, and is thought to contribute to analgesia. Also, many reports such as action to inhibit "itch", a promotor action of the bone metabolism, and the follicular maturation acceleration action have tested and elucidated these mechanisms, and will add further adaptation that will be new in future. Furthermore, development and downsizing of the free electron laser will promote elucidation of the low response level laser therapy. We expect much in the future of the LLLT.

Entities:  

Mesh:

Year:  2012        PMID: 22860300

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  3 in total

1.  The effect of low level laser therapy for pain in major muscles controlling two joints.

Authors:  Takashi Harada; Midori Miyagi; Hideaki Izukura; Gou Endou; Nobuyuki Ushigome; Hiroshi Tsuruoka; Akito Mizutani; Toshio Ohshiro; Satoru Ebihara
Journal:  Laser Ther       Date:  2019-06-30

2.  The Effect on Muscle Hardness of Acupuncture Stimulation Using Low-reactive Level Laser Therapy and Silver Spike Point Therapy, along with Stretching.

Authors:  Tadashi Sawada; Nao Tateyama; Takara Ikeda; Keisou Ishimaru
Journal:  Laser Ther       Date:  2020-07-17

3.  Blue-light treatment reduces spontaneous and evoked pain in a human experimental pain model.

Authors:  Anna Maria Reuss; Dominik Groos; Robert Scholl; Marco Schröter; Christian Maihöfner
Journal:  Pain Rep       Date:  2021-12-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.